APR 25, 2018 7:00 AM PDT

Integrating Hematology and Coagulation Results to Enhance Diagnosis

Sponsored by: Abbott Diagnostics
C.E. Credits: P.A.C.E. CE Florida CE
  • Manager, Medical and Scientific Affairs, Hematology, Abbott Diagnostics
      Dr. Larry Smith received his doctorate in biological sciences from Fordham University, Bronx, New York, and completed his certificate in molecular laboratory diagnostics at Michigan State University, East Lansing, Michigan. He completed his postdoctoral studies in gene therapy and experimental hematopoiesis at Columbia University College of Physicians and Surgeons, New York, New York, and was a research fellow in immunology at Fordham University and at the Laboratory of Lymphokine Biology at the New York Blood Center's Lindsley F. Kimball Research Institute, New York, New York. In addition, Dr. Smith has a Master of Science in medical biology and a Bachelor of Science in French and biology.

      His former positions include Research Associate and Director of the Stem Cell Research Laboratory, Division of Hematology-Oncology, at Long Island College Hospital, Brooklyn, New York; Adjunct Associate Professor at Rutgers School of Health Related Professions, Newark, New Jersey; Adjunct Professor at the School of Health Sciences and Professional Programs, York College, City University of New York, Jamaica, New York; and Director of the Coagulation and Hemostasis Laboratories, Assistant Attending Laboratory Scientist for the Department of Clinical Laboratories, and Associate Director of Clinical Hematology Laboratories at Memorial Sloan Kettering Cancer Center, New York, New York.

      Dr. Smith is a member of the American Association for Clinical Chemistry, the Academy of Clinical Laboratory Physicians and Scientists, the American Society for Clinical Pathology, the American Society of Clinical Laboratory Science, the American Society of Hematology, the International Academy of Clinical and Applied Thrombosis/Hemostasis, the International Society for Laboratory Hematology, and the International Society on Thrombosis and Hemostasis.

      Dr. Smith holds multiple board certificates and has published numerous peer-reviewed articles, abstracts, reviews and monographs. He is the co-author of several textbooks on hematology and coagulation and has been an invited presenter at both national and international conferences. His research interests include laboratory test development for hemostasis and coagulation, HPC therapeutic applications, and flow cytometry.


    DATE: April 25, 2018

    TIME: 07:00am PDT, 10:00am EDT, 1500 CEST


    Hematology and coagulation laboratories perform a wide range of routine and specialized tests for the screening, diagnosis, treatment and prognosis of hematological disorders.


    Advances in technology, together with the variety of tests being performed in each area of the laboratory, mean that healthcare scientists are now able to deliver better information.  Abnormalities seen in hematology testing might have significant clinical impact in coagulation testing.


    In this webinar, Dr. Smith will discuss three cases that share abnormal findings across both disciplines.  These abnormal findings, taken together, aid in an enhanced diagnosis to help the clinician deliver improved patient outcomes.


    Learning Objectives:

    • Describe the pathogenesis of Acute Promyelocytic Leukemia (APL), Chronic Lymphocytic Leukemia (CLL) and Thrombotic Thrombocytopenic Purpura (TTP)

    • Review the hematological profile of APL, CLL and TTP cases

    • Outline mechanisms associated with the coagulopathy in APL, CLL, and TTP

    • Describe the need for both hematology and coagulation in the diagnoses of APL, CLL and TTP


    Don't miss a future webinar.  Sign up today to receive updates.

    Show Resources
    Show Resources
    Connect with us